Dr. Ralf Schirrmacher
Dr. Ralf Schirrmacher PhD studied Chemistry/Radiochemistry in Cologne, Germany from 1990 until 1999 where he acquired his PhD at Mainz University. After a brief stint at the University of Pennsylvania working under Dr. Chin Shiu and Dr. Abass Alavi, he returned to Germany to assume a position as lead radiochemist at the Department of Nuclear Medicine at Mainz University where he stayed until 2006. In 2007 he was appointed Associate Professor at McGill University where he became a Canada Research Chair Tier II for Radiochemistry and worked as Director of Cyclotron at the world renowned Montreal Neurological Institute and the Lady Davis Institute for Medical Research. After getting tenure in 2012 he continued working at the McConnell Brain Imaging Centre developing new radioligands for brain PET. In 2014 he assumed a position as an Associate Professor at the University of Alberta in the Department of Oncology where he was promoted to full professor in 2018. Dr. Schirrmacher is an adjunct member of Pharmacy and Chemistry.
Dr. Justin Bailey
Dr. Justin Bailey originally came from the province of British Columbia to pursue his undergraduate degree in Chemistry and Biology at the University of Alberta. In 2008, he moved on to pursue his Ph.D. in carbohydrate chemistry at the University of Alberta under the guidance of Prof. David R. Bundle. After completing his graduate studies, he served a short Industrial Postdoctoral Fellowship with the Alberta Glycomics Centre in collaboration with NovaDigm Therapeutics before accepting his current position as a Research Associate in Prof. Ralf Schirrmacher's laboratory in 2014. In 2018, Justin founded the university spin-off company Cerberus Radiopharmaceuticals with the focus of expanding and commercializing the intellectual property developed in Ralf's laboratory. His research interests include carbohydrate and medicinal chemistry, immunology, chemical biology, and of course, radiochemistry.
Travis Kronemann is a second year Honours Physiology student at the University of Alberta. He joined the Schirrmacher group as a department of Oncology summer student in the Faculty of Medicine and Dentistry and has since been a Chemistry 299 research student. He works on the development of radio-tracers for oncological treatment and imaging.
Carolin Jaworski - Visiting Graduate Student
Carolin’s home university is the “Technische Universität Dortmund” in Germany, where she got her Bachelor’s degree in Chemistry and started her studies for her Master’s degree. She decided to do her research internship and the studies for her Master thesis at the University of Alberta, more precisely in the research group of Prof. Dr. Ralf Schirrmacher. The contact was established over a former doctoral student from the university in Dortmund.
The stay abroad in Canada is partly funded by “BAföG”, which gives young people the opportunity to receive that kind of education, which suits their abilities and interests the best.
When Carolin isn’t studying at the University she enjoys the beautiful Canadian Nature.
Pu Yinglan studied from September 2011 to July 2015 as an undergraduate student at Shanxi University of Science and Technology. She graduated as a postgraduate student in June 2018, majored in Pharmaceutical Engineering and specialized in Pharmaceutical Chemistry and Computer Aid Drug Design (CADD). In the first year of her postgraduate study, she mainly focused on the area of CADD at Sichuan University of Science and Engineering. In her second and third year, she was working at Kunming Institute of Botany, Chinese Academy of Science with Professor Zuo Zhili, did synthetic work and helped partners perform bioassays. She already published three papers as first author and holds one patent. Apart from attending classes, she also worked in Professor Kong Yang`s lab, taking part in the research area of phytochemistry, on the research topic “Extraction and Separation of Secondary Metabolites of Oleander.” Pu will start her PhD at the Chemistry Department of the University of Alberta in the Schirrmacher group in January 2019 on radiolabeling of novel cancer imaging agents and neuro-PET chemistry.
My name is Nathaniel Tetteh. I completed my BSc Chemistry (2012) from the Kwame Nkrumah university of Science and Technology (KNUST), Kumasi-Ghana. Working as a production Chemist for two and a half years in the pharmaceutical industry, I then moved to Kingston Canada to pursue my MSc in Chemistry from Queen's University (2018).
I am currently a PhD student at the department of Chemistry, University of Alberta. My research is focused on radiolabelling of nanoparticles embedded in stimuli-responsive microgels for positron emission tomography (PET) imaging of cancer. The ability of these materials to release active drugs at target sites in response to specific environmental conditions would also be explored. During my free time, I like to read and listen to music.